Latest News for: abx

Edit

Abalos Therapeutics to Present Preclinical Data Highlighting Potent, Synergistic Effects of ABX-001 in Combination with ...

Nasdaq Globe Newswire 04 Nov 2025
Abalos to present preclinical data on ABX-001 and its potential to further intensify anti-tumoral effects when combined with bispecific T-cell engagers ... .
Edit

Abalos Therapeutics Doses First Patient in Phase 1 Study Evaluating ABX-001 for the Treatment of ...

Nasdaq Globe Newswire 23 Oct 2025
-- First-in-class non-oncolytic arenavirus-based approach designed to induce targeted, effective, and durable anti-cancer activity against primary tumors and metastases – ... .
Edit

Abalos Therapeutics Publishes in Cell Reports Medicine Validating ABX-001’s Potential to Overcome Cancer Immunotherapy Hurdles

Nasdaq Globe Newswire 14 Oct 2025
-- Preclinical data support Abalos’ first-in-class approach of safely harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to treat solid tumors -- ... .
  • 1
×